 | • レポートコード：MRC2312MG16380 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の眼科用インプラント製品市場規模と予測を収録しています。・世界の眼科用インプラント製品市場：売上、2018年-2023年、2024年-2029年 ・世界の眼科用インプラント製品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の眼科用インプラント製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生分解性」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 眼科用インプラント製品のグローバル主要企業は、Abbive、 Alimera Sciences、 Bausch + Lomb、 EyePoint Pharmaceuticals、 Genentech、 Regeneron Pharmaceuticals、 Allergan、 OcuMensionなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、眼科用インプラント製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の眼科用インプラント製品市場：タイプ別、2018年-2023年、2024年-2029年 世界の眼科用インプラント製品市場：タイプ別市場シェア、2022年 ・生分解性、非生分解性 世界の眼科用インプラント製品市場：用途別、2018年-2023年、2024年-2029年 世界の眼科用インプラント製品市場：用途別市場シェア、2022年 ・病院、クリニック 世界の眼科用インプラント製品市場：地域・国別、2018年-2023年、2024年-2029年 世界の眼科用インプラント製品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における眼科用インプラント製品のグローバル売上、2018年-2023年 ・主要企業における眼科用インプラント製品のグローバル売上シェア、2022年 ・主要企業における眼科用インプラント製品のグローバル販売量、2018年-2023年 ・主要企業における眼科用インプラント製品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Abbive、 Alimera Sciences、 Bausch + Lomb、 EyePoint Pharmaceuticals、 Genentech、 Regeneron Pharmaceuticals、 Allergan、 OcuMension ************************************************************* ・調査・分析レポートの概要 眼科用インプラント製品市場の定義 市場セグメント 世界の眼科用インプラント製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の眼科用インプラント製品市場規模 世界の眼科用インプラント製品市場規模：2022年 VS 2029年 世界の眼科用インプラント製品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの眼科用インプラント製品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の眼科用インプラント製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生分解性、非生分解性 眼科用インプラント製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック 眼科用インプラント製品の用途別グローバル売上・予測 ・地域別市場分析 地域別眼科用インプラント製品市場規模 2022年と2029年 地域別眼科用インプラント製品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Abbive、 Alimera Sciences、 Bausch + Lomb、 EyePoint Pharmaceuticals、 Genentech、 Regeneron Pharmaceuticals、 Allergan、 OcuMension ... |
This research report provides a comprehensive analysis of the Ophthalmic Implant Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Ophthalmic Implant Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Ophthalmic Implant Products, challenges faced by the industry, and potential opportunities for market players.
The global Ophthalmic Implant Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Ophthalmic Implant Products market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Ophthalmic Implant Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Ophthalmic Implant Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Ophthalmic Implant Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Ophthalmic Implant Products market.
Market Overview: The report provides a comprehensive overview of the Ophthalmic Implant Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biodegradable, Non-biodegradable), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Ophthalmic Implant Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Ophthalmic Implant Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Ophthalmic Implant Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Ophthalmic Implant Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Ophthalmic Implant Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Ophthalmic Implant Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Ophthalmic Implant Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Ophthalmic Implant Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Ophthalmic Implant Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Biodegradable
Non-biodegradable
Market segment by Application
Hospital
Clinic
Global Ophthalmic Implant Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbive
Alimera Sciences
Bausch + Lomb
EyePoint Pharmaceuticals
Genentech
Regeneron Pharmaceuticals
Allergan
OcuMension
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Implant Products, market overview.
Chapter 2: Global Ophthalmic Implant Products market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Implant Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Implant Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Implant Products capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Implant Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Implant Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Implant Products Overall Market Size
2.1 Global Ophthalmic Implant Products Market Size: 2022 VS 2029
2.2 Global Ophthalmic Implant Products Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ophthalmic Implant Products Sales: 2018-2029
3 Company Landscape
3.1 Top Ophthalmic Implant Products Players in Global Market
3.2 Top Global Ophthalmic Implant Products Companies Ranked by Revenue
3.3 Global Ophthalmic Implant Products Revenue by Companies
3.4 Global Ophthalmic Implant Products Sales by Companies
3.5 Global Ophthalmic Implant Products Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ophthalmic Implant Products Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ophthalmic Implant Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Implant Products Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Implant Products Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Implant Products Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ophthalmic Implant Products Market Size Markets, 2022 & 2029
4.1.2 Biodegradable
4.1.3 Non-biodegradable
4.2 By Type – Global Ophthalmic Implant Products Revenue & Forecasts
4.2.1 By Type – Global Ophthalmic Implant Products Revenue, 2018-2023
4.2.2 By Type – Global Ophthalmic Implant Products Revenue, 2024-2029
4.2.3 By Type – Global Ophthalmic Implant Products Revenue Market Share, 2018-2029
4.3 By Type – Global Ophthalmic Implant Products Sales & Forecasts
4.3.1 By Type – Global Ophthalmic Implant Products Sales, 2018-2023
4.3.2 By Type – Global Ophthalmic Implant Products Sales, 2024-2029
4.3.3 By Type – Global Ophthalmic Implant Products Sales Market Share, 2018-2029
4.4 By Type – Global Ophthalmic Implant Products Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ophthalmic Implant Products Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Ophthalmic Implant Products Revenue & Forecasts
5.2.1 By Application – Global Ophthalmic Implant Products Revenue, 2018-2023
5.2.2 By Application – Global Ophthalmic Implant Products Revenue, 2024-2029
5.2.3 By Application – Global Ophthalmic Implant Products Revenue Market Share, 2018-2029
5.3 By Application – Global Ophthalmic Implant Products Sales & Forecasts
5.3.1 By Application – Global Ophthalmic Implant Products Sales, 2018-2023
5.3.2 By Application – Global Ophthalmic Implant Products Sales, 2024-2029
5.3.3 By Application – Global Ophthalmic Implant Products Sales Market Share, 2018-2029
5.4 By Application – Global Ophthalmic Implant Products Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ophthalmic Implant Products Market Size, 2022 & 2029
6.2 By Region – Global Ophthalmic Implant Products Revenue & Forecasts
6.2.1 By Region – Global Ophthalmic Implant Products Revenue, 2018-2023
6.2.2 By Region – Global Ophthalmic Implant Products Revenue, 2024-2029
6.2.3 By Region – Global Ophthalmic Implant Products Revenue Market Share, 2018-2029
6.3 By Region – Global Ophthalmic Implant Products Sales & Forecasts
6.3.1 By Region – Global Ophthalmic Implant Products Sales, 2018-2023
6.3.2 By Region – Global Ophthalmic Implant Products Sales, 2024-2029
6.3.3 By Region – Global Ophthalmic Implant Products Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ophthalmic Implant Products Revenue, 2018-2029
6.4.2 By Country – North America Ophthalmic Implant Products Sales, 2018-2029
6.4.3 US Ophthalmic Implant Products Market Size, 2018-2029
6.4.4 Canada Ophthalmic Implant Products Market Size, 2018-2029
6.4.5 Mexico Ophthalmic Implant Products Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ophthalmic Implant Products Revenue, 2018-2029
6.5.2 By Country – Europe Ophthalmic Implant Products Sales, 2018-2029
6.5.3 Germany Ophthalmic Implant Products Market Size, 2018-2029
6.5.4 France Ophthalmic Implant Products Market Size, 2018-2029
6.5.5 U.K. Ophthalmic Implant Products Market Size, 2018-2029
6.5.6 Italy Ophthalmic Implant Products Market Size, 2018-2029
6.5.7 Russia Ophthalmic Implant Products Market Size, 2018-2029
6.5.8 Nordic Countries Ophthalmic Implant Products Market Size, 2018-2029
6.5.9 Benelux Ophthalmic Implant Products Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ophthalmic Implant Products Revenue, 2018-2029
6.6.2 By Region – Asia Ophthalmic Implant Products Sales, 2018-2029
6.6.3 China Ophthalmic Implant Products Market Size, 2018-2029
6.6.4 Japan Ophthalmic Implant Products Market Size, 2018-2029
6.6.5 South Korea Ophthalmic Implant Products Market Size, 2018-2029
6.6.6 Southeast Asia Ophthalmic Implant Products Market Size, 2018-2029
6.6.7 India Ophthalmic Implant Products Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ophthalmic Implant Products Revenue, 2018-2029
6.7.2 By Country – South America Ophthalmic Implant Products Sales, 2018-2029
6.7.3 Brazil Ophthalmic Implant Products Market Size, 2018-2029
6.7.4 Argentina Ophthalmic Implant Products Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ophthalmic Implant Products Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ophthalmic Implant Products Sales, 2018-2029
6.8.3 Turkey Ophthalmic Implant Products Market Size, 2018-2029
6.8.4 Israel Ophthalmic Implant Products Market Size, 2018-2029
6.8.5 Saudi Arabia Ophthalmic Implant Products Market Size, 2018-2029
6.8.6 UAE Ophthalmic Implant Products Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbive
7.1.1 Abbive Company Summary
7.1.2 Abbive Business Overview
7.1.3 Abbive Ophthalmic Implant Products Major Product Offerings
7.1.4 Abbive Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.1.5 Abbive Key News & Latest Developments
7.2 Alimera Sciences
7.2.1 Alimera Sciences Company Summary
7.2.2 Alimera Sciences Business Overview
7.2.3 Alimera Sciences Ophthalmic Implant Products Major Product Offerings
7.2.4 Alimera Sciences Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.2.5 Alimera Sciences Key News & Latest Developments
7.3 Bausch + Lomb
7.3.1 Bausch + Lomb Company Summary
7.3.2 Bausch + Lomb Business Overview
7.3.3 Bausch + Lomb Ophthalmic Implant Products Major Product Offerings
7.3.4 Bausch + Lomb Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.3.5 Bausch + Lomb Key News & Latest Developments
7.4 EyePoint Pharmaceuticals
7.4.1 EyePoint Pharmaceuticals Company Summary
7.4.2 EyePoint Pharmaceuticals Business Overview
7.4.3 EyePoint Pharmaceuticals Ophthalmic Implant Products Major Product Offerings
7.4.4 EyePoint Pharmaceuticals Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.4.5 EyePoint Pharmaceuticals Key News & Latest Developments
7.5 Genentech
7.5.1 Genentech Company Summary
7.5.2 Genentech Business Overview
7.5.3 Genentech Ophthalmic Implant Products Major Product Offerings
7.5.4 Genentech Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.5.5 Genentech Key News & Latest Developments
7.6 Regeneron Pharmaceuticals
7.6.1 Regeneron Pharmaceuticals Company Summary
7.6.2 Regeneron Pharmaceuticals Business Overview
7.6.3 Regeneron Pharmaceuticals Ophthalmic Implant Products Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.6.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Company Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Ophthalmic Implant Products Major Product Offerings
7.7.4 Allergan Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.7.5 Allergan Key News & Latest Developments
7.8 OcuMension
7.8.1 OcuMension Company Summary
7.8.2 OcuMension Business Overview
7.8.3 OcuMension Ophthalmic Implant Products Major Product Offerings
7.8.4 OcuMension Ophthalmic Implant Products Sales and Revenue in Global (2018-2023)
7.8.5 OcuMension Key News & Latest Developments
8 Global Ophthalmic Implant Products Production Capacity, Analysis
8.1 Global Ophthalmic Implant Products Production Capacity, 2018-2029
8.2 Ophthalmic Implant Products Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Implant Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Implant Products Supply Chain Analysis
10.1 Ophthalmic Implant Products Industry Value Chain
10.2 Ophthalmic Implant Products Upstream Market
10.3 Ophthalmic Implant Products Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Implant Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer